A Systematic Review of Population-Based Studies of Chronic Bowel Symptoms in Cancer Survivors following Pelvic Radiotherapy.

cancer survivorship chronic bowel symptoms gynecological cancer pelvic radiation disease pelvic radiotherapy prostate cancer radiotherapy radiotherapy late-effects systematic review

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
09 Aug 2023
Historique:
received: 11 07 2023
revised: 02 08 2023
accepted: 03 08 2023
medline: 26 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Pelvic radiotherapy can damage surrounding tissue and organs, causing chronic conditions including bowel symptoms. We systematically identified quantitative, population-based studies of patient-reported bowel symptoms following pelvic radiotherapy to synthesize evidence of symptom type, prevalence, and severity. Medline, CINAHL, EMBASE, and PsychINFO were searched from inception to September 2022. Following independent screening of titles, abstracts, and full-texts, population and study characteristics and symptom findings were extracted, and narrative synthesis was conducted. In total, 45 papers (prostate,

Identifiants

pubmed: 37627064
pii: cancers15164037
doi: 10.3390/cancers15164037
pmc: PMC10452492
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : 3D-Matrix
ID : Unrestricted Project Grant

Références

Clin Oncol (R Coll Radiol). 2007 Dec;19(10):790-9
pubmed: 17904338
Gynecol Oncol. 2012 Oct;127(1):153-60
pubmed: 22704950
J Cancer Surviv. 2015 Jun;9(2):361-72
pubmed: 25563819
J Natl Cancer Inst. 2000 Oct 4;92(19):1582-92
pubmed: 11018094
J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67
pubmed: 15367568
Br J Cancer. 2018 May;118(11):1518-1528
pubmed: 29755116
Cancer. 2003 Apr 1;97(7):1653-62
pubmed: 12655522
Clin Colon Rectal Surg. 2015 Jun;28(2):103-11
pubmed: 26034407
Acta Obstet Gynecol Scand. 2002 May;81(5):443-50
pubmed: 12027819
Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):116-126
pubmed: 30102188
Acta Oncol. 2002;41(6):532-42
pubmed: 12546526
BJU Int. 2018 Nov;122(5):845-857
pubmed: 29489050
BMJ. 2009 Nov 27;339:b4817
pubmed: 19945997
Gynecol Oncol. 2021 Apr;161(1):4-10
pubmed: 33223220
J Cancer Surviv. 2022 Aug;16(4):834-843
pubmed: 34414517
Cancer. 2002 Jul 1;95(1):82-9
pubmed: 12115320
J Clin Oncol. 2001 May 1;19(9):2517-26
pubmed: 11331331
PLoS One. 2013 Dec 30;8(12):e80092
pubmed: 24386076
Scand J Gastroenterol. 2011 Apr;46(4):389-97
pubmed: 21189094
Urol Oncol. 2020 Dec;38(12):930.e23-930.e32
pubmed: 32736934
Clin Transl Radiat Oncol. 2022 Aug 19;37:19-24
pubmed: 36052020
Br J Cancer. 2017 Mar 28;116(7):864-873
pubmed: 28222069
Urol Oncol. 2022 Feb;40(2):56.e1-56.e8
pubmed: 34154899
BJU Int. 2015 Sep;116(3):397-406
pubmed: 25597493
ANZ J Surg. 2003 Sep;73(9):712-6
pubmed: 12956787
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Int J Gynecol Cancer. 2010 Apr;20(3):449-60
pubmed: 20375813
Urology. 1996 Mar;47(3):387-94
pubmed: 8633407
Cancer. 2021 Jun 1;127(11):1912-1925
pubmed: 33595853
J Clin Oncol. 2017 Jul 10;35(20):2306-2314
pubmed: 28493812
Lancet Oncol. 2019 Mar;20(3):436-447
pubmed: 30713036
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1196-1203
pubmed: 32717261
Dig Dis Sci. 2018 Sep;63(9):2180-2188
pubmed: 29948565
BJU Int. 2016 Jun;117(6B):E36-45
pubmed: 25959859
Clin Oncol (R Coll Radiol). 2018 Jun;30(6):334-345
pubmed: 29459102
J Cancer Surviv. 2020 Apr;14(2):135-150
pubmed: 32162193
PLoS One. 2017 Feb 3;12(2):e0171461
pubmed: 28158314
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1219-1229
pubmed: 33279595
N Engl J Med. 2013 Jan 31;368(5):436-45
pubmed: 23363497
Clin Transl Radiat Oncol. 2022 Aug 06;37:78-84
pubmed: 36093341
BMJ. 2020 Oct 7;371:m3503
pubmed: 33028540
Eur Urol. 2017 Aug;72(2):307-314
pubmed: 27816300
BJU Int. 2013 Feb;111(2):221-32
pubmed: 22672151
J Urol. 2022 Dec;208(6):1226-1239
pubmed: 36006050
Psychooncology. 2014 Jun;23(6):672-8
pubmed: 24481859
Eur J Cancer. 2010 Feb;46(3):606-15
pubmed: 19926277
J Clin Oncol. 2020 Mar 1;38(7):744-752
pubmed: 31895608
Radiother Oncol. 2010 Nov;97(2):294-300
pubmed: 20447707
Cancer. 2002 Feb 1;94(3):862-71
pubmed: 11857323
Radiother Oncol. 2004 Aug;72(2):139-45
pubmed: 15297133
Can Urol Assoc J. 2020 Apr;14(4):111-117
pubmed: 31702548
Radiat Oncol. 2018 Aug 29;13(1):162
pubmed: 30157890
JAMA. 2017 Mar 21;317(11):1126-1140
pubmed: 28324093
JAMA. 2017 Mar 21;317(11):1141-1150
pubmed: 28324092
Radiother Oncol. 2021 Feb;155:48-55
pubmed: 33075390
Cancer Epidemiol. 2020 Feb;64:101623
pubmed: 31760356
Br J Nurs. 2017 Feb 23;26(4):S15-S22
pubmed: 28230440
Urol Pract. 2018 Nov;5(6):471-479
pubmed: 37312333
JAMA. 2020 Jan 14;323(2):149-163
pubmed: 31935027
J Clin Oncol. 2004 Oct 15;22(20):4193-201
pubmed: 15483030
Clin Endosc. 2022 Jan;55(1):22-32
pubmed: 34788934
Eur Urol. 2019 Sep;76(3):391-397
pubmed: 30857758
Eur Urol. 2018 Jul;74(1):26-33
pubmed: 29501451
JAMA Netw Open. 2021 Nov 1;4(11):e2129647
pubmed: 34724555
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):30-8
pubmed: 18538503
J Med Imaging Radiat Oncol. 2016 Jun;60(3):420-7
pubmed: 26763604

Auteurs

Adam Biran (A)

Centre for Cancer, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Iakov Bolnykh (I)

Centre for Cancer, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Ben Rimmer (B)

Centre for Cancer, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Anthony Cunliffe (A)

NHS Southwest London Clinical Commissioning Group, London SW19 1RH, UK.

Lisa Durrant (L)

Somerset NHS Foundation Trust, Taunton TA1 5DA, UK.

John Hancock (J)

North Tees and Hartlepool NHS Foundation Trust, Hartlepool TS24 9AH, UK.

Helen Ludlow (H)

Llandough, Cardiff and Vale University Health Board, Cardiff CF64 2XX, UK.

Ian Pedley (I)

Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne NE3 3HD, UK.

Colin Rees (C)

Centre for Cancer, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Linda Sharp (L)

Centre for Cancer, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Classifications MeSH